NAVB Projected Dividend Yield
Navidea Biopharmaceuticals Inc ( OTCBB : NAVB )Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It is developing multiple precision-targeted products based on its Manocept platform to enhance patient care by identifying the sites and pathways of undetected disease. Co.'s business is focused on two primary types of drug products, such as diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform, and therapeutic development programs, including therapeutic applications of its Manocept platform. 21 YEAR PERFORMANCE RESULTS |
NAVB Dividend History Detail NAVB Dividend News NAVB Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |